Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Finckh

Showing results (171-180 of 225) with videos related to

Pageof 23
Sort By:
RMD Open|August 16, 2019
Current status of use of big data and artificial intelligence in RMDs: a systematic literature review informing EULAR recommendationsJoanna Kedra, Timothy Radstake, Aridaman Pandit, et al.
JAMA Neurology|February 25, 2022
Omicron-Specific Cytotoxic T-Cell Responses After a Third Dose of mRNA COVID-19 Vaccine Among Patients With Multiple Sclerosis Treated With OcrelizumabNatacha Madelon, Nelli Heikkilä, Irène Sabater Royo, et al.
Annals of the Rheumatic Diseases|June 24, 2019
EULAR points to consider for the use of big data in rheumatic and musculoskeletal diseasesLaure Gossec, Joanna Kedra, Hervé Servy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 18, 2021
Robust T-Cell Responses in Anti-CD20-Treated Patients Following COVID-19 Vaccination: A Prospective Cohort StudyNatacha Madelon, Kim Lauper, Gautier Breville, et al.
Clinical Rheumatology|June 8, 2023
Anaemia is associated with higher disease activity in axial spondyloarthritis but is not an independent predictor of spinal radiographic progression: data from the Swiss Clinical Quality Management RegistryRaphael Micheroli, Seraphina Kissling, Kristina Bürki, et al.
Arthritis Research & Therapy|June 12, 2023
Safety outcomes in patients with rheumatoid arthritis treated with abatacept: results from a multinational surveillance study across seven European registriesAlyssa Dominique, Merete Lund Hetland, Axel Finckh, et al.
Rheumatology (Oxford, England)|September 2, 2017
Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritisDeshiré Alpizar-Rodriguez, Rüdiger B Mueller, Burkhard Möller, et al.
The Journal of Rheumatology|August 13, 2009
Multiple computer-based methods of measuring joint space width can discriminate between treatment arms in the COBRA trial -- Update of an ongoing OMERACT projectJohn T Sharp, Jane Angwin, Maarten Boers, et al.
Scientific Reports|October 18, 2023
Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical careMyriam Riek, Almut Scherer, Burkhard Möller, et al.
RMD Open|June 23, 2026
Site-specific articular responses to b/tsDMARDs in rheumatoid arthritis: a longitudinal observational study from the Swiss Clinical Quality Management RegistryAnnik Steimer, Andrea Götschi, Jonas Brändli, et al.
Pageof 23

Showing results (171-180 of 225) with videos related to

Sort By:
Pageof 23
RMD Open|August 16, 2019
Current status of use of big data and artificial intelligence in RMDs: a systematic literature review informing EULAR recommendationsJoanna Kedra, Timothy Radstake, Aridaman Pandit, et al.
JAMA Neurology|February 25, 2022
Omicron-Specific Cytotoxic T-Cell Responses After a Third Dose of mRNA COVID-19 Vaccine Among Patients With Multiple Sclerosis Treated With OcrelizumabNatacha Madelon, Nelli Heikkilä, Irène Sabater Royo, et al.
Annals of the Rheumatic Diseases|June 24, 2019
EULAR points to consider for the use of big data in rheumatic and musculoskeletal diseasesLaure Gossec, Joanna Kedra, Hervé Servy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 18, 2021
Robust T-Cell Responses in Anti-CD20-Treated Patients Following COVID-19 Vaccination: A Prospective Cohort StudyNatacha Madelon, Kim Lauper, Gautier Breville, et al.
Clinical Rheumatology|June 8, 2023
Anaemia is associated with higher disease activity in axial spondyloarthritis but is not an independent predictor of spinal radiographic progression: data from the Swiss Clinical Quality Management RegistryRaphael Micheroli, Seraphina Kissling, Kristina Bürki, et al.
Arthritis Research & Therapy|June 12, 2023
Safety outcomes in patients with rheumatoid arthritis treated with abatacept: results from a multinational surveillance study across seven European registriesAlyssa Dominique, Merete Lund Hetland, Axel Finckh, et al.
Rheumatology (Oxford, England)|September 2, 2017
Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritisDeshiré Alpizar-Rodriguez, Rüdiger B Mueller, Burkhard Möller, et al.
The Journal of Rheumatology|August 13, 2009
Multiple computer-based methods of measuring joint space width can discriminate between treatment arms in the COBRA trial -- Update of an ongoing OMERACT projectJohn T Sharp, Jane Angwin, Maarten Boers, et al.
Scientific Reports|October 18, 2023
Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical careMyriam Riek, Almut Scherer, Burkhard Möller, et al.
RMD Open|June 23, 2026
Site-specific articular responses to b/tsDMARDs in rheumatoid arthritis: a longitudinal observational study from the Swiss Clinical Quality Management RegistryAnnik Steimer, Andrea Götschi, Jonas Brändli, et al.
Pageof 23